Open search
Home
Publications
Journal of the Neurological Sciences
JNS Vol 485 | June 2026

JNS-cover.jpgJournal of Neurological Sciences

Vol 485 | 15 June 2026

Editorial Board

Published in issue: June 15, 2026, 125933

 

Basic Research Papers

Evidence for compromised function of the glymphatic system in pediatric acquired demyelinating disorders

Florencia Ontiveros, Whitney I. Mattson, Camille S. Wilson, ... Aliyah I. Webb, Alexander Douma, Eric E. Nelson

The effect of end-tidal carbon dioxide levels on dynamic cerebral autoregulation and clinical outcome in acute ischemic stroke: An INFOMATAS study

Lauren M. Walker, Ricardo C. Nogueira, Terrie Vasilopoulos, ... Ronney B. Panerai, Thompson G. Robinson, Jatinder S. Minhas

Modeling inter-slice dependencies with temporal graph learning for Alzheimer's disease

Taymaz Akan, Md. Shenuarin Bhuiyand, Steven A. Conrad, John A. Vanchiere, Mohammad Alfrad Nobel Bhuiyan

Fronto-medial theta instability error signal correlates with postural sway in Parkinson's disease and progressive supranuclear palsy

Rex Lloyd, Clodagh O'Keeffe, John Inocentes, ... Tim Lynch, Richard B. Reilly, Conor Fearon

Stroke preventive strategies and long-term cognitive function: A population-based study

Wenling Chang, Majed Obaid, Charles D.A. Wolfe, ... Ajay Bhalla, Matthew DL O'Connell, Abdel Douiri

Polygenic and spatial insights into the genetic uniqueness of essential tremor using common variants

Miranda Medeiros, Dylan Gharibian, Patrick A. Dion, Guy A. Rouleau

Agreement between the simplified Edinburgh CT criteria and the Boston MRI criteria v2.0 for cerebral amyloid angiopathy diagnosis in lobar intracerebral hemorrhage from a population-based perspective. Dijon Stroke Registry

Hermine Annic, Gauthier Duloquin, Pierre-Olivier Comby, ... Frédéric Ricolfi, Serge Aho, Yannick Béjot

Epidemiology, treatment practices, and societal and economic burden of Duchenne muscular dystrophy in Finland: A retrospective register and chart review study

Pirjo Isohanni, Mari Auranen, Aino Vesikansa, Juha Mehtälä, Mira Kyttälä, Mikko Kosunen

Clinical Short Communication

Clocks out of sync: Increased epigenetic aging variability in multiple sclerosis

Fernanda L. Schumacher, Gary Cutter, Christin E. Burd, Kellie Archer, Yinan Zhang

Letters to the Editor

Response to “Comment on ‘efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis’”

Warda Ahmed, Om H. Gandhi, Omar Choudhri

Letter regarding impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network

Amirreza Saeedi Goraghani, Ali Abasi

Dural arteriovenous fistula in transient global amnesia: Why further reporting matters

Rafael Batista João, Raquel Mattos Filgueiras

Comment on “Safety and efficacy of vigabatrin add on compared to placebo in Lennox-Gastaut syndrome (LennoVig): A single center randomized double-blind placebo-controlled trial”

Shubhrajit Mantry, Prabhat Kumar Das, Shaktiprasad Pradhan

Comment on “CSF and plasma GFAP and VEGF in adult type 3 spinal muscular atrophy patients treated with nusinersen”

Sadhana U. Adhyapak, Abhishek Kumar Upadhyay, S.R.V. Prasad Reddy

Response to the letter of the editor on “association of symptoms of neuropsychological long COVID with imaging and plasma biomarkers”

Taizen Nakase

Toward a disease-specific framework for preventive neurology

Daniel Jesudason, Tharshanah Thayabaranathan, Sonali Gnanenthiran

Clinical utility of blood neurofilament light chain (bNfL); a comment

Reza Sharifi, Ali Alavi, Amirreza Darabi

Response to comment by Srinivasan et al. on “Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis”

Warda Ahmed, Om H. Gandhi, Omar Choudhri

Response to Letter to the Editor – Association of biological age markers with stroke prevalence: Insights from a cross-sectional study

Shengyan Cui, Xiao Zhang, Tao Wang, Liqun Jiao

Comment on “Modeling inter-slice dependencies with temporal graph learning for Alzheimer's disease”

Hengrui Zhang, Hanxi Yan

Comment on “Cost-effectiveness analysis of high-efficacy drugs used in the treatment of multiple sclerosis in a large health insurance provider in Brazil”

Miduthuru Sukumar, Kabilan Annadurai

Comments on: “Correlation between blood biomarkers and patient-reported outcomes (PROs) of depression and mental health scores in individuals with multiple sclerosis (iwMS)”

Baharuddin Baharuddin, Ami Febriza, Lilies Handayani, Maher M. Akl

Comment on “Oxidative stress and inflammatory response in cerebral infarction due to hyperlipidemia and lipid-lowering, anti-inflammatory, and antioxidant therapy”

Richa Kothari, Ashish Sarkar, Arijit Chaudhuri

Comment on “Correlation between blood biomarkers and patient-reported outcomes (PROs) of depression and mental health scores in Individuals with Multiple Sclerosis (iwMS)”

Mohammed Misbah Ul Haq, Shaik Mohd Shoaib

Riboflavin deficiency myelopathy

Ethan Meltzer

Intention-to-treat reality, MOH reversion, and mechanistic insights: Reframing the 12-month CGRP mAb experience

Yingtong Chen, Lihua Xuan

Early acute-phase cognitive screening to optimize return to work after ischemic stroke: Clinical implications and global research priorities

Longping Ye, Hengping Chen

Response to letter to the editor

Authors response to comment on “Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features”

Maria Petracca, Sirio Cocozza, Renato Cuocolo

Comment on “Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features”

Anuradha Mokkapati, Rhushvi Thakkar, Anjna Rani, Dinesh Puri

Comment on “association of symptoms of neuropsychological long COVID with imaging and plasma biomarkers”

Wanhua Qiu

Association of biological age markers with stroke prevalence: Methodological considerations and future directions

Yilu Bao, Jiezhen Peng

Response to letter to the editor on the article “AQP4 levels in CSF correlate with clinical severity in iNPH patients: A pilot study”

Enrico Belgrado, Francesco Tuniz, Daniele Piccolo, ... Marco Vindigni, Mariarosaria Valente, Yan Tereshko

CSF AQP4 in iNPH: Biomarker of disease severity or surrogate of astrocytic dysfunction?

Chunhui Wang

Comment on “Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis”

Mengdi Zhang

Response to the letter to the editor (JOTNS-D-26-00685 by Mantry et al) longer and larger are better than shorter and smaller

Jayantee Kalita, Firoz M. Nizami

 
 
 
 

Journal of Neurological Sciences

JNS Vol 484 | May 2026

JNS Vol 483 | April 2026

JNS Vol 482 | March 2026

JNS Vol 481 | February 2026

JNS Vol 480 | January 2026

JNS Vol 479 | December 2025

JNS Vol 478 | November 2025

JNS Vol 476 | September 2025

JNS Vol 477 | October 2025

JNS Vol 475 | August 2025

JNS Vol 474 | July 2025

JNS Vol 473 | June 2025

JNS Vol 472 | May 2025

JNS Vol 471 | April 2025

JNS Vol 470 | March 2025

JNS Vol 469 | February 2025

JNS Vol 468 | January 2025

JNS Vol 467 | December 2024

JNS Vol 466 | November 2024

JNS Vol 465 | October 2024

JNS Vol 464 | September 2024

JNS Vol 463 | August 2024

JNS Vol 462 | July 2024

JNS Vol 461 | June 2024

JNS Vol 460 | May 2024

Prev 1 3 ... 6
 
 
 
 
Home | Terms of Use | Site Map | Privacy and cookies | Contact Us | Manage cookies
Copyright © 2026 World Federation of Neurology. All rights reserved.

Web design by Tribal Systems